Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 97

Results For "2023"

1182 News Found

Lupin Digital Health reveals results of digital therapeutics study with ACS patients
Digitisation | March 18, 2023

Lupin Digital Health reveals results of digital therapeutics study with ACS patients

The one-year-long study was aimed to evaluate the efficacy of LDH's digital therapeutics platform


Aster DM Healthcare appoints Dr. Nitish Shetty as India CEO
People | March 18, 2023

Aster DM Healthcare appoints Dr. Nitish Shetty as India CEO

He is Proficient in overseeing and leading teams for running successful business operations


Briefs: Man Industries, Jeevan Scientific Technology, Unichem and Torrent Pharmaceuticals
Drug Approval | March 18, 2023

Briefs: Man Industries, Jeevan Scientific Technology, Unichem and Torrent Pharmaceuticals

Man Industries (India) Limited has received a new export order of approximately Rs. 1,300 crores.


India can lead the “One Earth, One Health” vision, says Minister Mandaviya
Policy | March 16, 2023

India can lead the “One Earth, One Health” vision, says Minister Mandaviya

“One Earth, One Health” vision can become a reality only with active global collaboration where countries don’t think of only themselves, but of collective global outcomes


Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries
Healthcare | March 16, 2023

Apollo Hospitals crosses the landmark of 10,000+ robotic surgeries

Expands robotics to 20+ specialities


Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP
Drug Approval | March 15, 2023

Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Hydrochloride Capsules USP

Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million


Pfizer acquires Seagen for US$ 43 billion to battle cancer
News | March 14, 2023

Pfizer acquires Seagen for US$ 43 billion to battle cancer

Proposed combination enhances Pfizer’s position as a leading company in oncology


Briefs: Lupin and Alembic
News | March 14, 2023

Briefs: Lupin and Alembic

Lupin Bioresearch Centre conducts BA/BE, PK/PD, In-vitro BE and biosimilar studies.


Alpla and Inden pharma form joint venture
News | March 14, 2023

Alpla and Inden pharma form joint venture

ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma


Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division
Drug Approval | March 13, 2023

Shilpa Medicare gets 2 minor observations from USFDA for Unit VII, Analytical Services Division

The company will be submitting the responses to US FDA observations within stipulated timeline